Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$43.63

1.15 (2.71%)

15:25
11/21/18
11/21
15:25
11/21/18
15:25

TESARO call volume above normal and directionally bullish

Bullish option flow detected in TESARO with 3,334 calls trading, 1.1x expected, and implied vol increasing almost 2 points to 143.04%. Jan-19 45 calls and Dec-18 50 calls are the most active options, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 0.13. Earnings are expected on February 26th.

  • 03

    Dec

TSRO Tesaro
$43.63

1.15 (2.71%)

11/09/18
PIPR
11/09/18
NO CHANGE
PIPR
Tesaro AMBER trial data incomplete, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond remained Neutral on Tesaro following what he calls "incomplete, if not disappointing" data for the company's AMBER trial evaluating anti-TIM-3 in combination with PD-1. That data, Raymond said, means waiting until 2019 for data from the higher dose arm. The analyst added that he has concerns on FY19 expectations for Tesaro's Zejula due to stagnating trends across the U.S. and the looming loss of full pricing in Germany next month, and is "comfortable remaining on the sidelines."
11/12/18
JEFF
11/12/18
NO CHANGE
Target $25
JEFF
Hold
Tesaro price target lowered to $25 from $38 at Jefferies
Jefferies analyst Eun Yang lowered her price target for Tesaro to $25 saying the company's new immune-oncology data is "underwhelming." With slowing Zejula sales growth, Tesaro has been increasingly focused on I/O programs, Yang tells investors in a research note. She believes the company's data for new I/O therapy "fails to show meaningful additive effects when combined with its anti-PD-1." The analyst keeps a Hold rating on Tesaro.
11/16/18
PIPR
11/16/18
NO CHANGE
Target $35
PIPR
Neutral
Piper Jaffray says 'hard pressed' to see the logic behind Tesaro deal
Piper Jaffray analyst Christopher Raymond kept his Neutral rating and $35 price target on Tesaro, saying that today's Bloomberg report about the company exploring a sale in response to interest from potential buyers was a "headscratcher". The analyst notes that it is difficult to see the logic behind the deal given the headwinds faced by Zejula in the U.S. and in Europe. Raymond adds that the company's immuno-oncology portfolio "is still not ready for prime time" and that he would not be among the buyers of Tesaro stock.
11/19/18
CANT
11/19/18
NO CHANGE
Target $68
CANT
Overweight
Tesaro could be worth $89-$97 per share in buyout, says Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young believes Tesaro (TSRO) could be valued at $89-$97 per share in a takeout scenario. The stock closed Friday up 31%, or $8.37, to $34.96 after Bloomberg reported that the company was exploring a sale after receiving some interest. The press article could be a way of garnering interest for the company beyond potentially initial interest, Young tells investors in a research note. In the past, she thinks Tesaro has been a potential takeout interest from biopharmaceutical companies. Companies like Amgen (AMGN), Gilead (GILD), and Celgene (CELG) have cancer platforms that could add a PARP inhibitor and benefit from Tesaro's various immuno-oncology pipeline assets, Young writes. She reiterates an Overweight rating on Tesaro with a $68 price target.

TODAY'S FREE FLY STORIES

IONS

Ionis Pharmaceuticals

$80.53

0.25 (0.31%)

12:20
03/21/19
03/21
12:20
03/21/19
12:20
Options
Notable interest in Ionis Pharmaceuticals call options »

Notable interest in Ionis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
03/21/19
03/21
12:17
03/21/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$21.24

0.48 (2.31%)

12:16
03/21/19
03/21
12:16
03/21/19
12:16
Conference/Events
Boingo Wireless management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 28

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
03/21/19
03/21
12:16
03/21/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.37

-92.1 (-28.74%)

, AAPL

Apple

$194.85

6.71 (3.57%)

12:12
03/21/19
03/21
12:12
03/21/19
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rising this…

BIIB

Biogen

$228.37

-92.1 (-28.74%)

AAPL

Apple

$194.85

6.71 (3.57%)

MU

Micron

$43.54

3.46 (8.63%)

F

Ford

$8.63

0.12 (1.41%)

AMZN

Amazon.com

$1,804.86

7.5 (0.42%)

SNAP

Snap

$10.87

-0.07 (-0.64%)

LEVI

Levi Strauss

$22.67

(0.00%)

SRNE

Sorrento Therapeutics

$4.32

0.83 (23.78%)

DRI

Darden

$116.20

7.58 (6.98%)

CSIQ

Canadian Solar

$19.76

-3.78 (-16.06%)

GES

Guess

$19.02

-3.08 (-13.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 21

    Mar

VREX

Varex Imaging

$34.09

0.13 (0.38%)

12:10
03/21/19
03/21
12:10
03/21/19
12:10
Conference/Events
Varex Imaging management to meet with Northland »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

CTL

CenturyLink

$11.98

0.08 (0.67%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
03/21/19
03/21
12:05
03/21/19
12:05
General news
Treasury announced a $113 B batch of coupon auctions »

Treasury announced a $113…

X

U.S. Steel

$20.46

0.68 (3.44%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Hot Stocks
U.S. Steel announces enhanced benefits for its non-represented employees »

United States Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVH

Evolent Health

$13.81

0.655 (4.98%)

12:04
03/21/19
03/21
12:04
03/21/19
12:04
Recommendations
Evolent Health analyst commentary  »

Recent indications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBDO

Banco Bradesco

$10.43

(0.00%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Banco Bradesco falls -7.2% »

Banco Bradesco is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$15.27

-1.72 (-10.12%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Intelsat falls -10.1% »

Intelsat is down -10.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$18.96

-3.14 (-14.21%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Guess falls -14.0% »

Guess is down -14.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$3.53

0.245 (7.46%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Crescent Point Energy rises 8.0% »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$25.50

2.595 (11.33%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Conagra Brands rises 11.4% »

Conagra Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CHAP

Chaparral Energy

$5.95

0.64 (12.05%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Chaparral Energy rises 12.2% »

Chaparral Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

11:59
03/21/19
03/21
11:59
03/21/19
11:59
Periodicals
Deutsche Bank board discussed Commerzbank merger for 3 hours, Reuters says »

Deutsche Bank's (DB)…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.26

-92.21 (-28.77%)

11:53
03/21/19
03/21
11:53
03/21/19
11:53
Downgrade
Biogen rating change at Cantor Fitzgerald »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

JAZZ

Jazz Pharmaceuticals

$136.47

2.74 (2.05%)

11:50
03/21/19
03/21
11:50
03/21/19
11:50
Recommendations
Jazz Pharmaceuticals analyst commentary at Wells Fargo »

Jazz appoval expected but…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
03/21/19
03/21
11:50
03/21/19
11:50
General news
Treasury's $95 B 4- and 8-week bill sales were mixed »

Treasury's $95 B 4-…

EVH

Evolent Health

$13.74

0.585 (4.45%)

11:47
03/21/19
03/21
11:47
03/21/19
11:47
Recommendations
Evolent Health analyst commentary at KeyBanc »

Kentucky Medicaid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$103.54

1.2 (1.17%)

11:45
03/21/19
03/21
11:45
03/21/19
11:45
Options
PayPal call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.75

-0.12 (-0.32%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
Conference/Events
Boston Scientific management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

ORHOF

Origin House

$0.00

(0.00%)

, ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
On The Fly
Rising High: An exclusive talk with cannabis brands company Origin House »

In this edition of…

ORHOF

Origin House

$0.00

(0.00%)

ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

APHA

Aphria

$9.98

-0.15 (-1.48%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$20.67

-0.59 (-2.78%)

CGC

Canopy Growth

$45.90

-0.9 (-1.92%)

TLRY

Tilray

$69.93

-0.7 (-0.99%)

IGC

India Globalization Capital

$2.02

0.12 (6.32%)

KNHBF

ICC International Cannabis

$0.00

(0.00%)

ORTFD

Biome Grow

$0.00

(0.00%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

OGRMF

Organigram

$0.00

(0.00%)

KSHB

KushCo Holdings

$0.00

(0.00%)

MMNFF

MedMen

$0.00

(0.00%)

ELLXF

Elixinol Global

$0.00

(0.00%)

PLNHF

Planet 13 Holdings

$0.00

(0.00%)

KHRNF

Khiron Life Sciences

$0.00

(0.00%)

LHSIF

Liberty Health Sciences

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

FB

Facebook

$164.56

-0.91 (-0.55%)

11:37
03/21/19
03/21
11:37
03/21/19
11:37
Hot Stocks
Facebook says issues fixed after finding user passwords readable by employees »

Facebook's VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.